Alexandra B. Kimball, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hidradenitis Suppurativa | 50 | 2024 | 172 | 21.320 |
Why?
|
| Psoriasis | 110 | 2023 | 909 | 21.090 |
Why?
|
| Dermatologic Agents | 35 | 2022 | 292 | 8.910 |
Why?
|
| Dermatology | 52 | 2024 | 901 | 7.820 |
Why?
|
| Acne Vulgaris | 20 | 2022 | 341 | 5.360 |
Why?
|
| Skin Diseases | 23 | 2020 | 1081 | 3.340 |
Why?
|
| Biological Products | 17 | 2023 | 884 | 3.230 |
Why?
|
| Severity of Illness Index | 65 | 2024 | 15555 | 2.820 |
Why?
|
| Pruritus | 8 | 2021 | 362 | 2.620 |
Why?
|
| Career Choice | 13 | 2016 | 743 | 2.400 |
Why?
|
| Antibodies, Monoclonal | 27 | 2022 | 9107 | 2.120 |
Why?
|
| Quality of Life | 40 | 2022 | 12977 | 1.870 |
Why?
|
| Appointments and Schedules | 5 | 2016 | 428 | 1.750 |
Why?
|
| Skin Aging | 5 | 2019 | 133 | 1.690 |
Why?
|
| Cost of Illness | 8 | 2023 | 1876 | 1.540 |
Why?
|
| Sunlight | 4 | 2024 | 333 | 1.420 |
Why?
|
| Anti-Inflammatory Agents | 11 | 2024 | 1781 | 1.420 |
Why?
|
| Mohs Surgery | 5 | 2011 | 204 | 1.400 |
Why?
|
| Pregnancy Complications | 10 | 2021 | 2891 | 1.320 |
Why?
|
| Humans | 305 | 2024 | 746630 | 1.310 |
Why?
|
| Double-Blind Method | 37 | 2024 | 12227 | 1.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2024 | 4343 | 1.240 |
Why?
|
| Receptors, Tumor Necrosis Factor | 9 | 2014 | 576 | 1.230 |
Why?
|
| Biological Therapy | 5 | 2022 | 134 | 1.220 |
Why?
|
| Dermatitis, Atopic | 5 | 2022 | 688 | 1.210 |
Why?
|
| Cicatrix | 4 | 2020 | 769 | 1.170 |
Why?
|
| Clobetasol | 4 | 2008 | 32 | 1.120 |
Why?
|
| Clindamycin | 3 | 2012 | 139 | 1.110 |
Why?
|
| Training Support | 4 | 2014 | 109 | 1.110 |
Why?
|
| Rosacea | 3 | 2014 | 56 | 1.100 |
Why?
|
| Female | 179 | 2024 | 382450 | 1.070 |
Why?
|
| Adult | 133 | 2024 | 215192 | 1.070 |
Why?
|
| Burnout, Professional | 4 | 2024 | 680 | 1.050 |
Why?
|
| Interleukin-23 | 10 | 2022 | 191 | 1.010 |
Why?
|
| Physician Assistants | 3 | 2015 | 188 | 0.990 |
Why?
|
| Skin Neoplasms | 13 | 2016 | 5685 | 0.970 |
Why?
|
| Job Satisfaction | 7 | 2017 | 523 | 0.970 |
Why?
|
| Reminder Systems | 4 | 2016 | 376 | 0.960 |
Why?
|
| Middle Aged | 117 | 2024 | 214618 | 0.950 |
Why?
|
| Dermatitis | 2 | 2022 | 199 | 0.940 |
Why?
|
| Male | 145 | 2024 | 351420 | 0.930 |
Why?
|
| Immunologic Factors | 6 | 2024 | 1567 | 0.930 |
Why?
|
| Immunoglobulin G | 10 | 2022 | 4481 | 0.920 |
Why?
|
| Skin | 16 | 2023 | 4389 | 0.910 |
Why?
|
| Treatment Outcome | 61 | 2024 | 63732 | 0.910 |
Why?
|
| Nurse Practitioners | 3 | 2015 | 266 | 0.900 |
Why?
|
| Pain Measurement | 7 | 2018 | 3442 | 0.870 |
Why?
|
| Patient Compliance | 7 | 2017 | 2676 | 0.870 |
Why?
|
| Sunscreening Agents | 4 | 2010 | 135 | 0.850 |
Why?
|
| Calcitriol | 3 | 2010 | 294 | 0.830 |
Why?
|
| Economic Recession | 2 | 2016 | 79 | 0.830 |
Why?
|
| Arthritis, Psoriatic | 4 | 2009 | 210 | 0.820 |
Why?
|
| Sebum | 1 | 2021 | 17 | 0.810 |
Why?
|
| Tretinoin | 3 | 2015 | 522 | 0.780 |
Why?
|
| Ambulatory Care | 5 | 2015 | 2730 | 0.780 |
Why?
|
| Registries | 12 | 2021 | 8173 | 0.780 |
Why?
|
| Placebos | 6 | 2020 | 1659 | 0.770 |
Why?
|
| Benzoyl Peroxide | 2 | 2011 | 18 | 0.760 |
Why?
|
| Drug Eruptions | 3 | 2016 | 317 | 0.750 |
Why?
|
| Hyperpigmentation | 2 | 2015 | 116 | 0.740 |
Why?
|
| Pregnancy Outcome | 7 | 2021 | 2853 | 0.740 |
Why?
|
| Ethinyl Estradiol | 2 | 2013 | 115 | 0.730 |
Why?
|
| Coal Tar | 2 | 2010 | 17 | 0.730 |
Why?
|
| Phototherapy | 5 | 2017 | 371 | 0.690 |
Why?
|
| Androstenes | 2 | 2013 | 173 | 0.680 |
Why?
|
| Comorbidity | 16 | 2021 | 10372 | 0.680 |
Why?
|
| Career Mobility | 2 | 2012 | 263 | 0.670 |
Why?
|
| Primary Health Care | 5 | 2021 | 4592 | 0.670 |
Why?
|
| Administration, Topical | 12 | 2019 | 688 | 0.670 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2014 | 441 | 0.660 |
Why?
|
| Interleukin-12 | 7 | 2020 | 579 | 0.650 |
Why?
|
| Contraceptives, Oral | 2 | 2014 | 550 | 0.650 |
Why?
|
| Skin Physiological Phenomena | 2 | 2012 | 188 | 0.650 |
Why?
|
| Workflow | 2 | 2014 | 836 | 0.640 |
Why?
|
| Physicians, Women | 6 | 2013 | 467 | 0.630 |
Why?
|
| Biological Factors | 1 | 2019 | 158 | 0.630 |
Why?
|
| Efficiency | 6 | 2011 | 465 | 0.620 |
Why?
|
| Placebo Effect | 3 | 2017 | 509 | 0.620 |
Why?
|
| Motivation | 3 | 2018 | 1966 | 0.620 |
Why?
|
| Faculty, Medical | 4 | 2017 | 1173 | 0.620 |
Why?
|
| Ultraviolet Rays | 2 | 2017 | 1058 | 0.610 |
Why?
|
| Pyrazines | 1 | 2024 | 1197 | 0.610 |
Why?
|
| Professional Practice | 5 | 2017 | 311 | 0.600 |
Why?
|
| Immunosuppressive Agents | 9 | 2020 | 4057 | 0.600 |
Why?
|
| Internship and Residency | 9 | 2017 | 5775 | 0.590 |
Why?
|
| Needs Assessment | 4 | 2018 | 1137 | 0.590 |
Why?
|
| Insurance Claim Reporting | 1 | 2018 | 161 | 0.580 |
Why?
|
| Young Adult | 40 | 2022 | 57163 | 0.580 |
Why?
|
| Skin Pigmentation | 3 | 2009 | 269 | 0.580 |
Why?
|
| United States | 45 | 2023 | 70437 | 0.570 |
Why?
|
| Biopsy | 5 | 2021 | 6734 | 0.570 |
Why?
|
| Baths | 2 | 2008 | 53 | 0.570 |
Why?
|
| Forecasting | 5 | 2018 | 2907 | 0.570 |
Why?
|
| Physicians, Primary Care | 2 | 2021 | 605 | 0.560 |
Why?
|
| Therapeutic Human Experimentation | 2 | 2006 | 43 | 0.560 |
Why?
|
| Databases, Factual | 7 | 2018 | 7815 | 0.550 |
Why?
|
| Adolescent | 39 | 2023 | 86278 | 0.550 |
Why?
|
| Skin Care | 2 | 2007 | 55 | 0.550 |
Why?
|
| Administration, Cutaneous | 9 | 2013 | 707 | 0.550 |
Why?
|
| Physicians | 8 | 2017 | 4536 | 0.550 |
Why?
|
| Interleukin-17 | 5 | 2024 | 894 | 0.540 |
Why?
|
| Waiting Lists | 4 | 2014 | 716 | 0.530 |
Why?
|
| Sensory Thresholds | 1 | 2017 | 378 | 0.520 |
Why?
|
| Medicine | 1 | 2024 | 931 | 0.520 |
Why?
|
| Self-Assessment | 2 | 2020 | 382 | 0.510 |
Why?
|
| Television | 1 | 2018 | 404 | 0.510 |
Why?
|
| Hospitalists | 1 | 2019 | 295 | 0.510 |
Why?
|
| Contraceptives, Oral, Combined | 3 | 2014 | 115 | 0.510 |
Why?
|
| Pain | 6 | 2020 | 4982 | 0.510 |
Why?
|